Heterocyclic Bioactive Small Molecules: Advances in Structure Analysis and Drug Discovery in Heterocyclic Chemistry
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: 31 October 2024 | Viewed by 216
Special Issue Editors
Interests: heterocyclic chemistry; medicinal chemistry; drug design; organic synthesis; chemical biology; kinase inhibitors; enzyme inhibitors; nucleic acids binders; lead optimization; antitumor agents; antibacterials; neuroprotective agents
Special Issues, Collections and Topics in MDPI journals
Interests: heterocyclic chemistry; medicinal chemistry; drug design; molecular modeling; cheminformatics tools; organic synthesis; chemical biology; kinase inhibitors; enzyme inhibitors; nucleic acids binders; lead optimization; antitumor agents; antibacterials; antiviral agents
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Most small molecule drug candidates, marketed therapeutic compounds, and extracted natural products are characterized by a heterocyclic scaffold. Therefore, advances in heterocyclic chemistry are of great interest to the drug discovery scientific community. In silico screening, new synthetic methods, structural analysis, and extraction of natural heterocyclic bioactive compounds can readily yield a wide range of molecules to discover new effective drugs for the pharmaceutical treatment of diseases.
This special Issue of Molecules is directed at collecting original research articles and reviews in the field of medicinal chemistry. In particular, manuscripts dealing with computational drug design; new synthetic strategies; flow, green, and combinatorial chemistry; phytochemical extraction methodologies; structure–activity relationship analysis; and biological activities of heterocyclic compounds are welcome.
Prof. Dr. Annamaria Martorana
Prof. Dr. Antonino Lauria
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- small molecules
- heterocyclic chemistry
- in silico study
- drug discovery
- medicinal chemistry
- targeted therapy
- natural heterocyclic compounds
- phytochemical extraction
- combinatorial chemistry
- flow chemistry
- green chemistry
